DVx Inc. Reports Non-Consolidated Financial Results for the First Six Months Ended Sep. 30, 2017; Provides Financial and Dividend Guidance for the Year Ending Mar. 31, 2018
October 30, 2017
Share
DVx Inc. reported non-consolidated financial results for the first six months ended Sep. 30, 2017. For the six months, the company reported operating profit of ¥760 million and profit of ¥464 million or ¥41.21 per Share on net sales of ¥18,892 million against operating profit of ¥706 million and profit of ¥459 million or ¥40.77 per Share on net sales of ¥17,132 million for the same period of last year. Net cash provided by operating activities was ¥580,622,000 against ¥723,759,000 for the same period of last year. Purchase of property, plant and equipment was ¥99,487,000 against ¥33,741,000 for the same period of last year. Purchase of intangible assets was ¥15,630,000 against ¥8,965,000 for the same period of last year.
For the year ending Mar. 31, 2018, the company expects, operating profit of ¥1,171 million and profit of ¥783 million or ¥69.50 per Share on net sales of ¥38,377 million.
For the year ending Mar. 31, 2018, the company expects to pay an year end dividend of ¥23 per share.
DVx Inc. is a Japan-based company mainly engaged in the sale of medical equipment for circulatory system diseases. The Company operates in two business segments. The Arrhythmia segment mainly sells cardiac pacemakers, implantable cardioverter-defibrillators (ICDs), electrode catheters and ablation catheters. The Ischemia segment is engaged in the import and sale of automated contrast medium injectors under the name ACIST, excimer laser angioplasty systems, as well as sale of coronary artery stent products as agency business. The others business is engaged in the sale of neurosurgical products, general surgery related products, gastrointestinal related products, radiation protection supplies, among others.
DVx Inc. Reports Non-Consolidated Financial Results for the First Six Months Ended Sep. 30, 2017; Provides Financial and Dividend Guidance for the Year Ending Mar. 31, 2018